Publication: Pathologic risk factors and oncologic outcomes in early-stage cervical cancer patients treated by radical hysterectomy and pelvic lymphadenectomy at a Thai University Hospital: A 7 year retrospective review
Issued Date
2015-01-01
Resource Type
ISSN
15137368
Other identifier(s)
2-s2.0-84944256107
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asian Pacific Journal of Cancer Prevention. Vol.16, No.14 (2015), 5951-5956
Suggested Citation
Irene Ruengkhachorn, Suwanit Therasakvichya, Malee Warnnissorn, Chairat Leelaphatanadit, Suthi Sangkarat, Jutatip Srisombat Pathologic risk factors and oncologic outcomes in early-stage cervical cancer patients treated by radical hysterectomy and pelvic lymphadenectomy at a Thai University Hospital: A 7 year retrospective review. Asian Pacific Journal of Cancer Prevention. Vol.16, No.14 (2015), 5951-5956. doi:10.7314/APJCP.2015.16.14.5951 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/35552
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Pathologic risk factors and oncologic outcomes in early-stage cervical cancer patients treated by radical hysterectomy and pelvic lymphadenectomy at a Thai University Hospital: A 7 year retrospective review
Other Contributor(s)
Abstract
Background: To evaluate the rate of pathologic high-risk factors, intermediate-risk factors, and treatment outcomes in early-stage cervical cancer patients undergoing radical hysterectomy and pelvic lymphadenectomy (RHPL). Materials and Methods: Medical records of stage IA-IIA1 cervical cancer patients who underwent RHPL during the 2006 to 2012 time period and patient follow-up data until December 2013 were reviewed. Results: Of 331 patients, 52 women (15.7%) had pathologic high-risk factors and 59 women (17.8%) had intermediate-risk factors without high-risk factors. All studied patients had an initial complete response. At median follow-up time of 40.9 months (range 1-103.3 months) and mean follow-up time of 43.3±25.3 months, 37 women had disease recurrence and 4 women had died of disease. The most common site of recurrence was the pelvis (64.8%). Five-year and 10-year disease free survival rates were 96.1% and 91.5%, respectively. Five-year and 10-year overall survival rates were 100% and 99.4%, respectively. Independent factors related to recurrence were pelvic node metastasis (odds ratio [OR], 2.670; 95%CI, 1.001-7.119), and > 1/3 cervical stromal invasion (OR, 3.763; 95%CI, 1.483-9.549). Conclusions: The rates of pathologic high-risk and intermediate-risk factors should be considered and disclosed when counseling patients regarding primary treatment by RHPL. Oncologic outcomes of primary surgical treatment for early-stage cervical carcinoma were found to be excellent.